Earnings Preview For Valens Co

Valens Co (NASDAQ:VLNS) is set to give its latest quarterly earnings report on Wednesday, 2022-04-13. Here's what investors need to know before the announcement. Analysts estimate that Valens Co will report an earnings per share (EPS) of $-0.22.

Valens Co (NASDAQ:VLNS) is set to give its latest quarterly earnings report on Wednesday, 2022-04-13. Here’s what investors need to know before the announcement.

Analysts estimate that Valens Co will report an earnings per share (EPS) of $-0.22.

Valens Co bulls will hope to hear the company to announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Here’s a look at Valens Co’s past performance and the resulting price change:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate
EPS Actual -0.34 -0.06 -0.05 -0.05
Price Change % -7.51% -11.23% -2.76% 18.65%

Stock Performance

Shares of Valens Co were trading at $1.3 as of April 11. Over the last 52-week period, shares are down 77.55%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

To track all upcoming earnings announcements, click here to use Benzinga Earnings Calendar.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Celyad Oncology Reports Q3 Financial Review As Of September 30, The Company Had Cash And Cash Equivalents Of $13.1M; Clinical Updates Expected By End Of Year For The Phase 1 Dose-escalation IMMUNICY-1 Trial For Lead ShRNA-based Allogeneic Car T Candida…

Company continues to transition business focus to monetizing unique cell therapy intellectual property and prioritizing R&D discovery Clinical updates expected by end of year for the Phase 1 dose-escalation

CYAD